Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease

Ji Hwan Lee, Hyun Suk Ahn, Eungkweon Kim, Tae-im Kim

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Purpose: We compared the efficacy and safety of sodium hyaluronate (SH) and carboxymethylcellulose (CMC) in treating mild to moderate dry eye. Methods: Sixty-seven patients with mild to moderate dry eye were enrolled in this prospective, randomized, blinded study. They were treated 6 times a day with preservative-free unit dose formula eyedrops containing 0.1% SH or 0.5% CMC for 8 weeks. Corneal and conjunctival staining with fluorescein, tear film breakup time, subjective symptoms, and adverse reactions were assessed at baseline, 4 weeks, and 8 weeks after treatment initiation. Results: Thirty-two patients were randomly assigned to the SH group and 33 were randomly assigned to the CMC group. Both the SH and CMC groups showed statistically significant improvements in corneal and conjunctival staining sum scores, tear film breakup time, and dry eye symptom score at 4 and 8 weeks after treatment initiation. However, there were no statistically significant differences in any of the indices between the 2 treatment groups. There were no significant adverse reactions observed during follow-up. Conclusions: The efficacies of SH and CMC were equivalent in treating mild to moderate dry eye. SH and CMC preservative-free artificial tear formulations appropriately manage dry eye sign and symptoms and show safety and efficacy when frequently administered in a unit dose formula.

Original languageEnglish
Pages (from-to)175-179
Number of pages5
JournalCornea
Volume30
Issue number2
DOIs
Publication statusPublished - 2011 Feb 1

Fingerprint

Carboxymethylcellulose Sodium
Eye Diseases
Hyaluronic Acid
Tears
Staining and Labeling
Safety
Ophthalmic Solutions
Fluorescein
Signs and Symptoms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

@article{b0a629c5f77a4846a9c957cf4b86bea2,
title = "Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease",
abstract = "Purpose: We compared the efficacy and safety of sodium hyaluronate (SH) and carboxymethylcellulose (CMC) in treating mild to moderate dry eye. Methods: Sixty-seven patients with mild to moderate dry eye were enrolled in this prospective, randomized, blinded study. They were treated 6 times a day with preservative-free unit dose formula eyedrops containing 0.1{\%} SH or 0.5{\%} CMC for 8 weeks. Corneal and conjunctival staining with fluorescein, tear film breakup time, subjective symptoms, and adverse reactions were assessed at baseline, 4 weeks, and 8 weeks after treatment initiation. Results: Thirty-two patients were randomly assigned to the SH group and 33 were randomly assigned to the CMC group. Both the SH and CMC groups showed statistically significant improvements in corneal and conjunctival staining sum scores, tear film breakup time, and dry eye symptom score at 4 and 8 weeks after treatment initiation. However, there were no statistically significant differences in any of the indices between the 2 treatment groups. There were no significant adverse reactions observed during follow-up. Conclusions: The efficacies of SH and CMC were equivalent in treating mild to moderate dry eye. SH and CMC preservative-free artificial tear formulations appropriately manage dry eye sign and symptoms and show safety and efficacy when frequently administered in a unit dose formula.",
author = "Lee, {Ji Hwan} and Ahn, {Hyun Suk} and Eungkweon Kim and Tae-im Kim",
year = "2011",
month = "2",
day = "1",
doi = "10.1097/ICO.0b013e3181e9adcc",
language = "English",
volume = "30",
pages = "175--179",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease. / Lee, Ji Hwan; Ahn, Hyun Suk; Kim, Eungkweon; Kim, Tae-im.

In: Cornea, Vol. 30, No. 2, 01.02.2011, p. 175-179.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease

AU - Lee, Ji Hwan

AU - Ahn, Hyun Suk

AU - Kim, Eungkweon

AU - Kim, Tae-im

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Purpose: We compared the efficacy and safety of sodium hyaluronate (SH) and carboxymethylcellulose (CMC) in treating mild to moderate dry eye. Methods: Sixty-seven patients with mild to moderate dry eye were enrolled in this prospective, randomized, blinded study. They were treated 6 times a day with preservative-free unit dose formula eyedrops containing 0.1% SH or 0.5% CMC for 8 weeks. Corneal and conjunctival staining with fluorescein, tear film breakup time, subjective symptoms, and adverse reactions were assessed at baseline, 4 weeks, and 8 weeks after treatment initiation. Results: Thirty-two patients were randomly assigned to the SH group and 33 were randomly assigned to the CMC group. Both the SH and CMC groups showed statistically significant improvements in corneal and conjunctival staining sum scores, tear film breakup time, and dry eye symptom score at 4 and 8 weeks after treatment initiation. However, there were no statistically significant differences in any of the indices between the 2 treatment groups. There were no significant adverse reactions observed during follow-up. Conclusions: The efficacies of SH and CMC were equivalent in treating mild to moderate dry eye. SH and CMC preservative-free artificial tear formulations appropriately manage dry eye sign and symptoms and show safety and efficacy when frequently administered in a unit dose formula.

AB - Purpose: We compared the efficacy and safety of sodium hyaluronate (SH) and carboxymethylcellulose (CMC) in treating mild to moderate dry eye. Methods: Sixty-seven patients with mild to moderate dry eye were enrolled in this prospective, randomized, blinded study. They were treated 6 times a day with preservative-free unit dose formula eyedrops containing 0.1% SH or 0.5% CMC for 8 weeks. Corneal and conjunctival staining with fluorescein, tear film breakup time, subjective symptoms, and adverse reactions were assessed at baseline, 4 weeks, and 8 weeks after treatment initiation. Results: Thirty-two patients were randomly assigned to the SH group and 33 were randomly assigned to the CMC group. Both the SH and CMC groups showed statistically significant improvements in corneal and conjunctival staining sum scores, tear film breakup time, and dry eye symptom score at 4 and 8 weeks after treatment initiation. However, there were no statistically significant differences in any of the indices between the 2 treatment groups. There were no significant adverse reactions observed during follow-up. Conclusions: The efficacies of SH and CMC were equivalent in treating mild to moderate dry eye. SH and CMC preservative-free artificial tear formulations appropriately manage dry eye sign and symptoms and show safety and efficacy when frequently administered in a unit dose formula.

UR - http://www.scopus.com/inward/record.url?scp=78651347260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651347260&partnerID=8YFLogxK

U2 - 10.1097/ICO.0b013e3181e9adcc

DO - 10.1097/ICO.0b013e3181e9adcc

M3 - Article

VL - 30

SP - 175

EP - 179

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 2

ER -